683 Capital Management »

Bridgebio Pharma shares owned by 683 Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 1.0M 1.70

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Bridgebio Pharma

D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
CSS
Alberta Investment Management Corporation
Calamos Advisors
Ameriprise Financial
Wolverine Asset Management
SSI Investment Management
Bank of America Corporation
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Bridgebio Pharma